HUP9802393A3 - Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates - Google Patents
Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediatesInfo
- Publication number
- HUP9802393A3 HUP9802393A3 HU9802393A HUP9802393A HUP9802393A3 HU P9802393 A3 HUP9802393 A3 HU P9802393A3 HU 9802393 A HU9802393 A HU 9802393A HU P9802393 A HUP9802393 A HU P9802393A HU P9802393 A3 HUP9802393 A3 HU P9802393A3
- Authority
- HU
- Hungary
- Prior art keywords
- intermediates
- preparation
- pharmaceutical compositions
- compositions containing
- benzothiazolone derivatives
- Prior art date
Links
- BXQNSPXDWSNUKE-UHFFFAOYSA-N 1,3-benzothiazole 1-oxide Chemical class C1=CC=C2S(=O)C=NC2=C1 BXQNSPXDWSNUKE-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9518952.8A GB9518952D0 (en) | 1995-09-15 | 1995-09-15 | Compounds |
| GBGB9614346.6A GB9614346D0 (en) | 1996-07-10 | 1996-07-10 | Benzothiazolone derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9802393A2 HUP9802393A2 (hu) | 1999-04-28 |
| HUP9802393A3 true HUP9802393A3 (en) | 2000-01-28 |
Family
ID=26307771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9802393A HUP9802393A3 (en) | 1995-09-15 | 1996-09-12 | Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates |
Country Status (29)
| Country | Link |
|---|---|
| US (5) | US5846989A (hu) |
| EP (1) | EP0850232B1 (hu) |
| JP (1) | JP3213327B2 (hu) |
| KR (1) | KR19990044674A (hu) |
| CN (2) | CN1073098C (hu) |
| AR (1) | AR004512A1 (hu) |
| AT (1) | ATE190610T1 (hu) |
| AU (1) | AU706094B2 (hu) |
| BR (1) | BR9610316A (hu) |
| CA (1) | CA2231003A1 (hu) |
| CY (1) | CY2227B1 (hu) |
| CZ (1) | CZ74098A3 (hu) |
| DE (1) | DE69607183T2 (hu) |
| EE (1) | EE03395B1 (hu) |
| ES (1) | ES2146901T3 (hu) |
| GR (1) | GR3033681T3 (hu) |
| HK (1) | HK1008781A1 (hu) |
| HU (1) | HUP9802393A3 (hu) |
| IL (4) | IL141955A0 (hu) |
| IS (1) | IS4679A (hu) |
| MY (1) | MY113518A (hu) |
| NO (1) | NO310721B1 (hu) |
| NZ (4) | NZ318007A (hu) |
| PL (1) | PL325517A1 (hu) |
| PT (1) | PT850232E (hu) |
| SK (1) | SK282394B6 (hu) |
| TR (1) | TR199800457T2 (hu) |
| TW (1) | TW356468B (hu) |
| WO (1) | WO1997010227A1 (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU742506B2 (en) * | 1997-10-17 | 2002-01-03 | Eurogene Limited | The use of inhibitors of the renin-angiotensin system |
| SE0004750D0 (sv) * | 2000-12-19 | 2000-12-19 | Astrazeneca Ab | Novel formulation |
| PE20050130A1 (es) * | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
| GB0218629D0 (en) * | 2002-08-09 | 2002-09-18 | Novartis Ag | Organic compounds |
| CA2543858C (en) * | 2003-11-21 | 2014-04-15 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| UA94235C2 (en) * | 2005-08-09 | 2011-04-26 | Астразенека Аб | Novel benzothiazolone derivatives |
| TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200740781A (en) * | 2005-08-29 | 2007-11-01 | Astrazeneca Ab | Novel compounds |
| TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| US20100056508A1 (en) * | 2006-12-20 | 2010-03-04 | Astrazeneca Ab | Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| WO2009154557A1 (en) | 2008-06-18 | 2009-12-23 | Astrazeneca Ab | Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
| EP2303266A4 (en) * | 2008-06-20 | 2015-01-21 | Astrazeneca Ab | PHARMACEUTICAL COMPOSITION COMPRISING A 4-HYDROXY-2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-7-YLE COMPOUND FOR THE MODULATION OF BETA-2-ADRENORECEPTOR ACTIVITY |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314944A (en) * | 1980-08-22 | 1982-02-09 | Smithkline Corporation | 4-Aminoalkyl-7-hydroxy-2(3H)-indolones |
| US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
| GB8426200D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
| US4554284A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones |
| US4554287A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones |
| DK514585A (da) * | 1984-11-08 | 1986-05-09 | Syntex Inc | Aminoethylanilinderivater |
| DE3728695A1 (de) * | 1987-08-25 | 1989-03-09 | Schering Ag | Neue benzimidazol-derivate |
| GB9024208D0 (en) * | 1990-11-07 | 1990-12-19 | Salutar Inc | Compounds |
| IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
| GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
| GB9210632D0 (en) * | 1992-05-19 | 1992-07-01 | Fisons Plc | Compounds |
-
1996
- 1996-09-11 TW TW085111075A patent/TW356468B/zh active
- 1996-09-12 PT PT96930256T patent/PT850232E/pt unknown
- 1996-09-12 CN CN96198311A patent/CN1073098C/zh not_active Expired - Fee Related
- 1996-09-12 WO PCT/GB1996/002247 patent/WO1997010227A1/en not_active Application Discontinuation
- 1996-09-12 SK SK295-98A patent/SK282394B6/sk unknown
- 1996-09-12 BR BR9610316A patent/BR9610316A/pt not_active Application Discontinuation
- 1996-09-12 IL IL14195596A patent/IL141955A0/xx unknown
- 1996-09-12 US US08/776,770 patent/US5846989A/en not_active Expired - Lifetime
- 1996-09-12 TR TR1998/00457T patent/TR199800457T2/xx unknown
- 1996-09-12 EP EP96930256A patent/EP0850232B1/en not_active Expired - Lifetime
- 1996-09-12 CA CA002231003A patent/CA2231003A1/en not_active Abandoned
- 1996-09-12 IL IL12363996A patent/IL123639A/en not_active IP Right Cessation
- 1996-09-12 KR KR1019980701929A patent/KR19990044674A/ko not_active Application Discontinuation
- 1996-09-12 JP JP51175297A patent/JP3213327B2/ja not_active Expired - Fee Related
- 1996-09-12 HU HU9802393A patent/HUP9802393A3/hu unknown
- 1996-09-12 AU AU69371/96A patent/AU706094B2/en not_active Ceased
- 1996-09-12 ES ES96930256T patent/ES2146901T3/es not_active Expired - Lifetime
- 1996-09-12 DE DE69607183T patent/DE69607183T2/de not_active Expired - Fee Related
- 1996-09-12 AT AT96930256T patent/ATE190610T1/de not_active IP Right Cessation
- 1996-09-12 PL PL96325517A patent/PL325517A1/xx unknown
- 1996-09-12 EE EE9800069A patent/EE03395B1/xx not_active IP Right Cessation
- 1996-09-12 NZ NZ318007A patent/NZ318007A/xx unknown
- 1996-09-12 CZ CZ98740A patent/CZ74098A3/cs unknown
- 1996-09-12 IL IL14195696A patent/IL141956A0/xx unknown
- 1996-09-12 IL IL141954??A patent/IL141954A0/xx unknown
- 1996-09-13 AR ARP960104355A patent/AR004512A1/es not_active Application Discontinuation
- 1996-09-13 MY MYPI96003788A patent/MY113518A/en unknown
-
1998
- 1998-03-04 IS IS4679A patent/IS4679A/is unknown
- 1998-03-12 NO NO19981104A patent/NO310721B1/no unknown
- 1998-07-29 HK HK98109506A patent/HK1008781A1/xx not_active IP Right Cessation
- 1998-09-02 US US09/146,047 patent/US6008365A/en not_active Expired - Lifetime
- 1998-09-02 US US09/145,281 patent/US5973167A/en not_active Expired - Lifetime
- 1998-09-02 US US09/146,046 patent/US5977384A/en not_active Expired - Lifetime
- 1998-09-02 US US09/146,048 patent/US6080869A/en not_active Expired - Lifetime
- 1998-10-19 NZ NZ332395A patent/NZ332395A/xx unknown
- 1998-10-19 NZ NZ332397A patent/NZ332397A/xx unknown
- 1998-10-19 NZ NZ332396A patent/NZ332396A/xx unknown
-
2000
- 2000-06-14 GR GR20000401368T patent/GR3033681T3/el not_active IP Right Cessation
- 2000-12-30 CN CN00137051A patent/CN1356323A/zh active Pending
-
2001
- 2001-07-20 CY CY0100016A patent/CY2227B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
| HUP9603494A3 (en) | Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof | |
| HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| HUP9602122A2 (en) | Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| HUP9603495A3 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
| HUP9700328A3 (en) | Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates | |
| ZA968945B (en) | 1,3-Dihydro-indol-2-one derivatives process for their preparation and the pharmaceutical compositions containing them | |
| HK1028769A1 (en) | 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof | |
| HK1010116A1 (en) | Naphthalene derivatives process for the preparation thereof and intermediates therefor and pharmaceutical compositions comprising them | |
| HUP9700358A3 (en) | New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0102307A3 (en) | Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates | |
| HUP9800138A3 (en) | 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| AU6362796A (en) | Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them | |
| HUP9602635A3 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP9803040A3 (en) | Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them | |
| IL112589A (en) | Polysubstituted-3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives process and novel intermediates for their preparation and pharmaceutical compositions containing them | |
| HUP9802393A3 (en) | Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates | |
| HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
| GB9617893D0 (en) | New pharmaceutical derivatives, process for obtaining them and pharmaceutical compositions containing them | |
| IL123900A0 (en) | New phenylamidine derivatives processes for preparing them and their use as pharmaceutical compositions | |
| HUP0001093A3 (en) | Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
| HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
| HUP9801068A3 (en) | 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them |